The highly anticipated rule, which would make explicit that LDTs are medical devices subject to FDA oversight, proposes to end the agency’s general enforcement discretion approach to such devices…. By: Jones Day
Previous Story
October is Cybersecurity Awareness Month – Takeaways for the Entire Year
Next Story
French Parliament Takes Steps to Regulate NFT Games
